Page last updated: 2024-09-03

ilomastat and Colitis Gravis

ilomastat has been researched along with Colitis Gravis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Wang, W; Wang, YD	1

Other Studies

1 other study(ies) available for ilomastat and Colitis Gravis

Article	Year
Protective effect of ilomastat on trinitrobenzenesulfonic acid-induced ulcerative colitis in rats. World journal of gastroenterology, 2008, Oct-07, Volume: 14, Issue:37 Topics: Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Colon; Disease Models, Animal; Dose-Response Relationship, Drug; Gastrointestinal Agents; Hydroxamic Acids; Immunohistochemistry; Indoles; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase Inhibitors; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-1; Trinitrobenzenesulfonic Acid	2008

Article

Year

Protective effect of ilomastat on trinitrobenzenesulfonic acid-induced ulcerative colitis in rats.

World journal of gastroenterology, 2008, Oct-07, Volume: 14, Issue:37

Topics: Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Colon; Disease Models, Animal; Dose-Response Relationship, Drug; Gastrointestinal Agents; Hydroxamic Acids; Immunohistochemistry; Indoles; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase Inhibitors; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-1; Trinitrobenzenesulfonic Acid

2008